Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000041440Phase 4Recruiting
Phase 4, randomised trial of esketamine in acute pain (2 arms), sponsored by Yantai Affiliated Hospital of Binzhou Medical College. Primary endpoints: Cumulative use of analgesic drugs during operation and 48 hours after operation, Additional times of analgesia pump in 48 hours after operation and 3 more. Started Jan 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000041440.